Questions can be addressed
Drug developers are welcome to
bring following problems to AIMS BioScience
- What
- How
- Who
-
What is the most efficienct way
to develop nonclinical/clinical evidence?
-
How the nonclinical/clinical studies
should be designed?
-
Who is the best partner to outsource
our nonclinical/clinical studies?
- When
- Where
- Why
-
When should we decide whether to
continue development?
-
Where are the experts who can suggest
the strategies in drug development?
-
Why our timelines are delayed and
why we fail to make the proper evidence?
What we do
AIMS BioScience is a contract development company
who is capable of
-
01
Establishment of
overall (nonclinical to clinical)
evaluation plan of
the pipeline
-
02
Suggestion of
the best nonclinical
methodology to
generate experimental
evidence
-
03
Optimal designing for
individual studies to
maximize their values
-
04
Translation of existing
evidence
(including PK-PD) to
support the rationale for
further development
-
05
Outsourcing and managing
studies to credible partners
(e.g. nonclinical &
clinical CROs)
-
06
Securing inputs from
various experts
as needed
-
07
Management of the project
to meet the pre-defined
timeline
Scope
Full-scope service
-
AIMS BioScience manages and operates the whole procedural contents during certain
development milestones
(e.g. late pre-clinical to phase I)
-
An outcome-based contract is suggested
On-demand service(Strategic planning or Study outsourcing)
-
AIMS BioScience performs only limited functions
requested by the sponsor
(e.g. overall clinical investigation plan suggestion)
-
An hourly contract is suggested